Clinical Trials Browser

Malignant Solid Neoplasm

Cervical Cancer Prevention

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

Childhood Hematopoietic and Lymphatic System Neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Extensive Stage Lung Small Cell Cancer

Recurrence, Lymphoma, Mantle-Cell

Ganglioneuroblastoma

Rhabdomyosarcoma

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute

Non-Muscle Invasive Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Sarcoma, Kaposi

Carcinoma, Non-Small-Cell Lung, Recurrence

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Carcinoma, Non-Small-Cell Lung

Multiple Myeloma

Breast Cancer Survivor

Colonic Neoplasms

Melanoma, Skin Neoplasms

GastroEsophageal Cancer

Breast Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Neoplasms, Colorectal Neoplasms, Anastomotic Leak

Clinical Trials

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Quality of End-of-Life Care for Children With Cancer

(CAN-IMPACT-IO

Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

START-lung

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

FIT-AML

Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

A Study of Propranolol to Treat Kaposi Sarcoma

LidCRM

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

A Randomized Phase II Study Evaluating Upfront SRT to All Brain Metastases Followed by Ivonescimab Plus Chemotherapy Versus Upfront Ivonescimab Plus Chemotherapy in Patients With Asymptomatic Active Brain Metastases From NSCLC

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

FoRtitude

EMPIRE

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

NeoBEMA

Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol

BRACE

COLAP-D3